Drug intelligence / Profile preview

hydrocortisone + oxytetracycline + polymyxin B

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Topical, Ophthalmic, Otic
01

Overview

Terra-Cortril (hydrocortisone + oxytetracycline + polymyxin B) is a topical combination medication consisting of a corticosteroid and two antibiotics. Hydrocortisone is a glucocorticoid that provides anti-inflammatory, anti-pruritic, and vasoconstrictive actions by binding to the glucocorticoid receptor. Oxytetracycline is a broad-spectrum tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. Polymyxin B is a polypeptide antibiotic that increases the permeability of the bacterial cell membrane, primarily targeting gram-negative organisms. This combination is classically indicated for the treatment of corticosteroid-responsive inflammatory conditions of the eye and ear where a bacterial infection is present. It is also being investigated as a topical treatment for pilonidal sinus wounds and has been used off-label in dentistry for conditions like dry socket.

Brand names
Terra-Cortril
Other names
hydrocortisone/oxytetracycline/polymyxin B
02

Targets

GR (Glucocorticoid receptor)Gram-negative bacterial lipopolysaccharide lipid A and outer membrane anionic phospholipidsBacterial Ribosome

Beyond the preview

Go deeper on hydrocortisone + oxytetracycline + polymyxin B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocortisone + oxytetracycline + polymyxin B.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call